Cell Genesys Inc. (CEGE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

400 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

Cell Genesys Inc. focuses on the research, development and commercialization of biological therapies for patients with cancer. This biotechnology company is developing cell-based cancer vaccines, oncolytic virus therapies and antiangiogenesis therapies.

View SEC Filings from CEGE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CEGE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CEGE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

POTTS JOHN T JR

  • Director
No longer subject to file 2009-10-14 0

SHENK THOMAS E

  • Director
No longer subject to file 2009-10-14 0

VERMA INDER M

  • Director
No longer subject to file 2009-10-14 0

SHERWIN STEPHEN A CHAIRMAN AND CEO

  • Officer
  • Director
No longer subject to file 2009-10-14 0

TIDWELL ROBERT H SVP CORP. DEVELOPMENT

  • Officer
No longer subject to file 2009-10-14 0

GOWER JAMES M

  • Director
No longer subject to file 2009-10-14 0

STEP EUGENE L

  • Director
No longer subject to file 2009-10-14 0

CARTER DAVID WARREN

  • Director
No longer subject to file 2009-10-14 0

CROWELL NANCY M

  • Director
No longer subject to file 2009-10-14 0

WINGER DENNIS L

  • Director
No longer subject to file 2009-10-14 0

TETLOW SHARON SVP & CFO

  • Officer
No longer subject to file 2009-10-14 0

BELSKY MARC VP FINANCE & CAO

  • Officer
No longer subject to file 2009-10-14 0

KOPP LEROY C

  • 10% Owner
No longer subject to file 2009-10-14 0

MCKINLEY CHRISTINE SVP HUMAN RESOURCES

  • Officer
17,573 2008-07-31 0

RAMSAY MICHAEL W SVP OPERATIONS

  • Officer
34,836 2008-07-31 0

WORKING PETER K SVP R&D

  • Officer
17,965 2008-07-31 0

GRUNDFEST CAROL C SVP REG AFFAIRS & PORTFOL MGMT

  • Officer
15,949 2008-07-31 0

HEGE KRISTEN VP CLINICAL RESEARCH

  • Officer
27,512 2008-07-31 0

DOW ROBERT J SVP & CHIEF MEDICAL OFFICER

  • Officer
14,620 2008-07-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments